Literature DB >> 11754374

CD44 expression in human gliomas.

Stella Maris Ranuncolo1, Virginia Ladeda, Sergio Specterman, Mirta Varela, José Lastiri, Ana Morandi, Elena Matos, Elisa Bal de Kier Joffé, Lydia Puricelli, María Guadalupe Pallotta.   

Abstract

BACKGROUND AND OBJECTIVES: Glioma invasiveness involves the attachment of tumor cells to the brain extracellular matrix, rich in hyaluronic acid (HA). CD44, the principal receptor for HA is found as a standard molecule (CD44s) or as variants (CD44v). We undertook a retrospective study to evaluate the expression pattern of CD44s, the isoforms CD44v3, v4/5 and v6 and to correlate their expression with clinical-anatomopathological parameters and survival rate.
METHODS: The expression of these molecules was evaluated immunohistochemically in 84 gliomas.
RESULTS: No expression of CD44v was detected in any tumors. CD44s staining of tumor cells was found in 70 of 84 (83.3%) of the gliomas. In 23 of 39 (59.0%) of the GBM more than the 70% of the cells were stained, while only 2 of 21 (9.5%) of LGA showed high expression. The association between CD44 and histological grade remained when the prognostic variables were considered in a multivariate analysis. Higher expression of CD44 was associated with worse overall survival rate; however, the Cox analysis indicated that survival was not associated with CD44.
CONCLUSIONS: Our results suggest that overexpression of CD44s could be relevant in determining the highly invasive behaviour of gliomas, though it does not behave as an independent prognostic factor for survival. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11754374     DOI: 10.1002/jso.10045

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  20 in total

1.  Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.

Authors:  Candace M Howard; Jagan Valluri; Anthony Alberico; Terrence Julien; Rida Mazagri; Robert Marsh; Hoyt Alastair; Antonio Cortese; Michael Griswold; Wanmei Wang; Krista Denning; Linda Brown; Pier Paolo Claudio
Journal:  Transl Oncol       Date:  2017-02-12       Impact factor: 4.243

2.  Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform.

Authors:  Badriprasad Ananthanarayanan; Yushan Kim; Sanjay Kumar
Journal:  Biomaterials       Date:  2011-08-05       Impact factor: 12.479

3.  The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).

Authors:  Kenji Tsuchihashi; Shogo Okazaki; Mitsuyo Ohmura; Miyuki Ishikawa; Oltea Sampetrean; Nobuyuki Onishi; Hiroaki Wakimoto; Momoko Yoshikawa; Ryo Seishima; Yoshimi Iwasaki; Takayuki Morikawa; Shinya Abe; Ayumi Takao; Misato Shimizu; Takashi Masuko; Motoo Nagane; Frank B Furnari; Tetsu Akiyama; Makoto Suematsu; Eishi Baba; Koichi Akashi; Hideyuki Saya; Osamu Nagano
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

4.  CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway.

Authors:  Mayumi Jijiwa; Habibe Demir; Snehalata Gupta; Crystal Leung; Kaushal Joshi; Nicholas Orozco; Tiffany Huang; Vedat O Yildiz; Ichiyo Shibahara; Jason A de Jesus; William H Yong; Paul S Mischel; Soledad Fernandez; Harley I Kornblum; Ichiro Nakano
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

5.  Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.

Authors:  Weikun Xiao; Rongyu Zhang; Alireza Sohrabi; Arshia Ehsanipour; Songping Sun; Jesse Liang; Christopher M Walthers; Lisa Ta; David A Nathanson; Stephanie K Seidlits
Journal:  Cancer Res       Date:  2017-12-27       Impact factor: 12.701

Review 6.  Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.

Authors:  Bernard L Maria; Nalin Gupta; Anne G Gilg; May Abdel-Wahab; Anthony P Leonard; Mark Slomiany; William G Wheeler; Lauren B Tolliver; Michael A Babcock; John T Lucas; Bryan P Toole
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

7.  Hyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitors.

Authors:  Sandra L Tye; Anne G Gilg; Lauren B Tolliver; William G Wheeler; Bryan P Toole; Bernard L Maria
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  Modulation of hyaluronan production by CD44 positive glioma cells.

Authors:  Marzenna Wiranowska; Sharron Ladd; Lynn C Moscinski; Bobbye Hill; Ed Haller; Katalin Mikecz; Anna Plaas
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

9.  A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion.

Authors:  Ivo J Huijbers; Marjan Iravani; Sergey Popov; David Robertson; Safa Al-Sarraj; Chris Jones; Clare M Isacke
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

10.  CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility.

Authors:  Yushan Kim; Sanjay Kumar
Journal:  Mol Cancer Res       Date:  2014-06-24       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.